Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
Giovanna Fattovich(University of Modena and Reggio Emilia), G. Realdi(University of Padua), F. Tremolada, Franco Noventa(University of Padua), Patrizia Fuschi(University of Verona), Anshul Bhalla, Paola Bonetti(Center for Pediatric Endocrinology Zurich), Antonio Solinas(University of Sassari), Jovan Basho(University of Verona), Corinne Njapoum(University of Verona), Piero Luigi Almasio(University of Palermo), F. Nevens(University of Verona), D. Mura(University of Verona), G. Diodati, Rachel Galassini, A. Tocco(University of Verona), H. C. Thomas(University of Verona), Françoise Degos(Inserm), JT Brouwer(University of Verona), C. Casarin(University of Verona), SW Schalm(University of Verona), G. Giustina(University of Verona)
Cited by 1,410
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
|Haematologica|2007|774
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
|New England Journal of Medicine|1992|685
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393